At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Diamondback 360® Coronary OAS Micro Crowndevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coronary Orbital Atherectomy System Study
In Brief
A clinical study evaluating Diamondback 360® Coronary OAS Micro Crown for CAD. Completed, enrolled 100 participants across 17 sites in 2 countries.
Detailed Summary
The purpose of the COAST clinical study data will be to utilize and to gain approval for commercializing the Micro Crown as part of the Coronary Orbital Atherectomy System (OAS).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCAD
CountriesJapan, United States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 2014
Enrollment StartJun 2014
Primary CompletionSep 2015
Study CompletionJun 2017
TodayJul 2026
First PostedMay 7, 2014
Enrollment StartJun 1, 2014
Primary CompletionSep 1, 2015
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.2 years ago
Interventions
Diamondback 360® Coronary OAS Micro Crowndevice
The Diamondback 360® Coronary OAS Micro Crown consists of a diamond-coated crown mounted to a shaft. The OAD ablates occlusive material in order to facilitate stent delivery. During orbit, forces press the crown against the coronary plaque, reducing calcified plaque on the vessel wall.